We are live on
!
Find out more
FPF
FNY Partners Fund Portfolio holdings
AUM
$185M
1-Year Est. Return
32.58%
This Fund
S&P 500
This Quarter
Est. Return
-2.65%
1 Year Est. Return
+32.58%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.32B
AUM Growth
–
Cap. Flow
+$437M
Cap. Flow
% of AUM
18.82%
Top 10 Holdings %
Top 10 Hldgs %
94.66%
Holding
599
New
593
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$221M |
| 2 |
STJ
St Jude Medical
STJ
|
+$42.8M |
| 3 |
ACAS
American Capital Ltd
ACAS
|
+$20.1M |
| 4 |
TechnipFMC
FTI
|
+$10.3M |
| 5 |
HOT
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
|
+$8.54M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 81.53% |
| 2 | Consumer Staples | 9.86% |
| 3 | Healthcare | 2.28% |
| 4 | Financials | 1.22% |
| 5 | Technology | 1.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Clorox
CLX
$12.4B
| $60K | ﹤0.01% |
+500
| New | +$59K |
|
277
Five Below
FIVE
$13.5B
| $60K | ﹤0.01% |
+1,500
| New | +$59K |
|
|
X
278
DELISTED
US Steel
X
| $59K | ﹤0.01% |
+1,800
| New | +$48.1K |
|
279
Bristol-Myers Squibb
BMY
$135B
| $58K | ﹤0.01% |
+1,000
| New | +$54.7K |
|
280
Dollar General
DG
$27B
| $58K | ﹤0.01% |
+778
| New | +$56.8K |
|
281
Kroger
KR
$35.5B
| $58K | ﹤0.01% |
+1,500
| New | +$48.9K |
|
|
NEWR
282
DELISTED
New Relic, Inc.
NEWR
| $56K | ﹤0.01% |
+2,000
| New | +$66K |
|
|
WUBA
283
DELISTED
58.com Inc
WUBA
| $56K | ﹤0.01% |
+2,000
| New | +$74.3K |
|
|
PNK
284
DELISTED
Pinnacle Entertainment Inc.
PNK
| $56K | ﹤0.01% |
+3,894
| New | +$52K |
|
285
Macy's
M
$5.87B
| $54K | ﹤0.01% |
+1,509
| New | +$58.7K |
|
|
SYUT
286
DELISTED
Synutra International, Inc.
SYUT
| $54K | ﹤0.01% |
+10,000
| New | +$48.2K |
|
287
ManpowerGroup
MAN
$2.93B
| $53K | ﹤0.01% |
+600
| New | +$49.5K |
|
|
IPXL
288
DELISTED
Impax Laboratories, Inc.
IPXL
| $53K | ﹤0.01% |
+4,000
| New | +$68.4K |
|
289
Biogen
BIIB
$32.1B
| $52K | ﹤0.01% |
+200
| New | +$59.3K |
|
290
Newmont
NEM
$135B
| $51K | ﹤0.01% |
+1,500
| New | +$51.2K |
|
|
SAGE
291
DELISTED
Sage Therapeutics
SAGE
| $51K | ﹤0.01% |
+1,000
| New | +$47.1K |
|
292
Boston Properties
BXP
$11.2B
| $50K | ﹤0.01% |
+400
| New | +$49.7K |
|
293
Qualcomm
QCOM
$173B
| $48K | ﹤0.01% |
+735
| New | +$49.4K |
|
294
Gerdau
GGB
$8.91B
| $47K | ﹤0.01% |
+18,900
| New | +$51.5K |
|
|
ZYNE
295
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $47K | ﹤0.01% |
+3,000
| New | +$40.4K |
|
296
Bread Financial
BFH
$4.08B
| $46K | ﹤0.01% |
+251
| New | +$43.7K |
|
297
Capital One
COF
$133B
| $46K | ﹤0.01% |
+523
| New | +$42.2K |
|
|
FRC
298
DELISTED
First Republic Bank
FRC
| $46K | ﹤0.01% |
+500
| New | +$40.8K |
|
299
Corpay
CPAY
$26.7B
| $45K | ﹤0.01% |
+320
| New | +$50.1K |
|
|
NFX
300
DELISTED
Newfield Exploration
NFX
| $45K | ﹤0.01% |
+1,100
| New | +$46.7K |
|
Similar funds
USG2
PAM
HWP
IHM
EP
DVM
LCM
PAM
FNY Partners Fund's Q4 2016 Portfolio in Review
Q4 2016 is the first quarter with a 13F filing on record for FNY Partners Fund, which disclosed 599 positions worth $2.32B. Its ten largest holdings account for 95% of the portfolio.
Its largest position is Procter & Gamble: 2,587,880 shares worth $218M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 82% of assets, followed by Consumer Staples and Healthcare.
- FNY Partners Fund's largest Q4 2016 buy was Procter & Gamble: 2,587,880 shares worth $218M.
- FNY Partners Fund's ten largest holdings make up 95% of its $2.32B portfolio in Q4 2016.
- FNY Partners Fund disclosed 599 positions in Q4 2016, its first 13F filing on record.
Based on FNY Partners Fund's 13F filing for Q4 2016, filed 9 Feb 2017.